Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Acumen Pharmaceuticals Inc (ABOS)

Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 111,148
  • Shares Outstanding, K 60,080
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,370 K
  • EBIT $ -93 M
  • EBITDA $ -96 M
  • 60-Month Beta -0.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.51

Options Overview Details

View History
  • Implied Volatility 370.17% ( +82.29%)
  • Historical Volatility 78.26%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 370.17% on 12/23/24
  • IV Low 10.88% on 10/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 9
  • Volume Avg (30-Day) 45
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 2,757
  • Open Int (30-Day) 2,550

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.47
  • Number of Estimates 3
  • High Estimate -0.37
  • Low Estimate -0.61
  • Prior Year -0.29
  • Growth Rate Est. (year over year) -62.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7150 +3.21%
on 12/19/24
2.4700 -28.34%
on 11/25/24
-0.6000 (-25.32%)
since 11/22/24
3-Month
1.7150 +3.21%
on 12/19/24
3.3600 -47.32%
on 11/11/24
-0.6000 (-25.32%)
since 09/23/24
52-Week
1.7150 +3.21%
on 12/19/24
5.0900 -65.23%
on 03/04/24
-1.8000 (-50.42%)
since 12/22/23

Most Recent Stories

More News
Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

ABOS : 1.7700 (-4.32%)
2 'Strong Buy'-Rated Stocks That Wall Street Believes Can Soar Over 360%

Analysts see enormous long-term potential in these two penny stocks.

ABOS : 1.7700 (-4.32%)
ELDN : 4.19 (-3.90%)
$SPX : 5,974.07 (+0.73%)
2 Penny Stocks Wall Street Expects to Soar Over 400%

These two penny stock companies, while risky and volatile, have the potential to generate massive returns, according to Wall Street's price forecasts.

ABOS : 1.7700 (-4.32%)
$SPX : 5,974.07 (+0.73%)
ELDN : 4.19 (-3.90%)

Business Summary

Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It involved in developing a novel disease for Alzheimer. The company's product pipeline consist ACU193. Acumen Pharmaceuticals Inc. is based in CHARLOTTESVILLE, Va.

See More

Key Turning Points

3rd Resistance Point 1.9193
2nd Resistance Point 1.8847
1st Resistance Point 1.8273
Last Price 1.7700
1st Support Level 1.7353
2nd Support Level 1.7007
3rd Support Level 1.6433

See More

52-Week High 5.0900
Fibonacci 61.8% 3.8008
Fibonacci 50% 3.4025
Fibonacci 38.2% 3.0043
Last Price 1.7700
52-Week Low 1.7150

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar